APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mucopolysaccharidosis Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mucopolysaccharidosis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchMucopolysaccharidosis Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Mucopolysaccharidosis Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Mucopolysaccharidosis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mucopolysaccharidosis Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Mucopolysaccharidosis Treatment Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Mucopolysaccharidosis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Mucopolysaccharidosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mucopolysaccharidosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mucopolysaccharidosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mucopolysaccharidosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mucopolysaccharidosis Treatment include Abeona Therapeutics Inc., ArmaGen, BioMarin, Denali Therapeutics, Genzyme Corporation, Lysogene, REGENXBIO Inc., Sangamo Therapeutics and Shire (Takeda Pharmaceutical Company Limited), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Mucopolysaccharidosis Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mucopolysaccharidosis Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mucopolysaccharidosis Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Mucopolysaccharidosis Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Mucopolysaccharidosis Treatment Segment by Company

Abeona Therapeutics Inc.

ArmaGen

BioMarin

Denali Therapeutics

Genzyme Corporation

Lysogene

REGENXBIO Inc.

Sangamo Therapeutics

Shire (Takeda Pharmaceutical Company Limited)

Ultragenyx Pharmaceutical

Mucopolysaccharidosis Treatment Segment by Type

Intravenous

Intracerebroventricular (ICV)

Mucopolysaccharidosis Treatment Segment by Application

Hospital

Clinic

Other

Mucopolysaccharidosis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mucopolysaccharidosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mucopolysaccharidosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mucopolysaccharidosis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Mucopolysaccharidosis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mucopolysaccharidosis Treatment industry.

Chapter 3: Detailed analysis of Mucopolysaccharidosis Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mucopolysaccharidosis Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Intravenous Table 3. Key Players of Intracerebroventricular (ICV) Table 4. Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Other Table 8. Global Mucopolysaccharidosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Mucopolysaccharidosis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Mucopolysaccharidosis Treatment Market Share by Region (2021-2026) Table 11. Global Mucopolysaccharidosis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Mucopolysaccharidosis Treatment Market Share by Region (2027-2032) Table 13. Mucopolysaccharidosis Treatment Industry Trends Table 14. Mucopolysaccharidosis Treatment Industry Drivers Table 15. Mucopolysaccharidosis Treatment Industry Opportunities and Challenges Table 16. Mucopolysaccharidosis Treatment Industry Restraints Table 17. Global Mucopolysaccharidosis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Mucopolysaccharidosis Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Mucopolysaccharidosis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Mucopolysaccharidosis Treatment Key Company Head Office and Area Served Table 21. Global Mucopolysaccharidosis Treatment Company, Product Type & Application Table 22. Global Mucopolysaccharidosis Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Mucopolysaccharidosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Mucopolysaccharidosis Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Mucopolysaccharidosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Mucopolysaccharidosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Mucopolysaccharidosis Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Mucopolysaccharidosis Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Mucopolysaccharidosis Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Mucopolysaccharidosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Mucopolysaccharidosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Mucopolysaccharidosis Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Mucopolysaccharidosis Treatment Revenue Market Share by Application (2027-2032) Table 35. Abeona Therapeutics Inc. Company Information Table 36. Abeona Therapeutics Inc. Business Overview Table 37. Abeona Therapeutics Inc. Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abeona Therapeutics Inc. Mucopolysaccharidosis Treatment Product Portfolio Table 39. Abeona Therapeutics Inc. Recent Development Table 40. ArmaGen Company Information Table 41. ArmaGen Business Overview Table 42. ArmaGen Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. ArmaGen Mucopolysaccharidosis Treatment Product Portfolio Table 44. ArmaGen Recent Development Table 45. BioMarin Company Information Table 46. BioMarin Business Overview Table 47. BioMarin Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BioMarin Mucopolysaccharidosis Treatment Product Portfolio Table 49. BioMarin Recent Development Table 50. Denali Therapeutics Company Information Table 51. Denali Therapeutics Business Overview Table 52. Denali Therapeutics Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Denali Therapeutics Mucopolysaccharidosis Treatment Product Portfolio Table 54. Denali Therapeutics Recent Development Table 55. Genzyme Corporation Company Information Table 56. Genzyme Corporation Business Overview Table 57. Genzyme Corporation Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Genzyme Corporation Mucopolysaccharidosis Treatment Product Portfolio Table 59. Genzyme Corporation Recent Development Table 60. Lysogene Company Information Table 61. Lysogene Business Overview Table 62. Lysogene Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Lysogene Mucopolysaccharidosis Treatment Product Portfolio Table 64. Lysogene Recent Development Table 65. REGENXBIO Inc. Company Information Table 66. REGENXBIO Inc. Business Overview Table 67. REGENXBIO Inc. Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. REGENXBIO Inc. Mucopolysaccharidosis Treatment Product Portfolio Table 69. REGENXBIO Inc. Recent Development Table 70. Sangamo Therapeutics Company Information Table 71. Sangamo Therapeutics Business Overview Table 72. Sangamo Therapeutics Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Sangamo Therapeutics Mucopolysaccharidosis Treatment Product Portfolio Table 74. Sangamo Therapeutics Recent Development Table 75. Shire (Takeda Pharmaceutical Company Limited) Company Information Table 76. Shire (Takeda Pharmaceutical Company Limited) Business Overview Table 77. Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Treatment Product Portfolio Table 79. Shire (Takeda Pharmaceutical Company Limited) Recent Development Table 80. Ultragenyx Pharmaceutical Company Information Table 81. Ultragenyx Pharmaceutical Business Overview Table 82. Ultragenyx Pharmaceutical Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Ultragenyx Pharmaceutical Mucopolysaccharidosis Treatment Product Portfolio Table 84. Ultragenyx Pharmaceutical Recent Development Table 85. North America Mucopolysaccharidosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Mucopolysaccharidosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Mucopolysaccharidosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Mucopolysaccharidosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Mucopolysaccharidosis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Mucopolysaccharidosis Treatment Market Size by Country (2021-2026) Table 91. North America Mucopolysaccharidosis Treatment Market Size by Country (2027-2032) Table 92. Europe Mucopolysaccharidosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Mucopolysaccharidosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Mucopolysaccharidosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Mucopolysaccharidosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Mucopolysaccharidosis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Mucopolysaccharidosis Treatment Market Size by Country (2021-2026) Table 98. Europe Mucopolysaccharidosis Treatment Market Size by Country (2027-2032) Table 99. China Mucopolysaccharidosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 100. China Mucopolysaccharidosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 101. China Mucopolysaccharidosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 102. China Mucopolysaccharidosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Mucopolysaccharidosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Mucopolysaccharidosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Mucopolysaccharidosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Mucopolysaccharidosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Mucopolysaccharidosis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Mucopolysaccharidosis Treatment Market Size by Country (2021-2026) Table 109. Asia Mucopolysaccharidosis Treatment Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Mucopolysaccharidosis Treatment Product Image Figure 2. Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Mucopolysaccharidosis Treatment Market Share by Type: 2025 VS 2032 Figure 4. Intravenous Image Figure 5. Intracerebroventricular (ICV) Image Figure 6. Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Mucopolysaccharidosis Treatment Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Mucopolysaccharidosis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 13. Global Mucopolysaccharidosis Treatment Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Mucopolysaccharidosis Treatment Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Mucopolysaccharidosis Treatment Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Mucopolysaccharidosis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Mucopolysaccharidosis Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Mucopolysaccharidosis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Mucopolysaccharidosis Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 23. North America Mucopolysaccharidosis Treatment Market Share by Type (2021-2032) Figure 24. North America Mucopolysaccharidosis Treatment Market Share by Application (2021-2032) Figure 25. North America Mucopolysaccharidosis Treatment Market Share by Country (2021-2032) Figure 26. United States Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 27. Canada Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Europe Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Mucopolysaccharidosis Treatment Market Share by Type (2021-2032) Figure 31. Europe Mucopolysaccharidosis Treatment Market Share by Application (2021-2032) Figure 32. Europe Mucopolysaccharidosis Treatment Market Share by Country (2021-2032) Figure 33. Germany Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 34. France Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 36. Italy Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Russia Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 39. China Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Mucopolysaccharidosis Treatment Market Share by Type (2021-2032) Figure 41. China Mucopolysaccharidosis Treatment Market Share by Application (2021-2032) Figure 42. Asia Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 43. Asia Mucopolysaccharidosis Treatment Market Share by Type (2021-2032) Figure 44. Asia Mucopolysaccharidosis Treatment Market Share by Application (2021-2032) Figure 45. Asia Mucopolysaccharidosis Treatment Market Share by Country (2021-2032) Figure 46. Japan Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 50. India Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Australia Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Share by Country (2021-2032) Figure 56. Brazil Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 61. UAE Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Chile Mucopolysaccharidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous
  • Intracerebroventricular (ICV)
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abeona Therapeutics Inc.
  • ArmaGen
  • BioMarin
  • Denali Therapeutics
  • Genzyme Corporation
  • Lysogene
  • REGENXBIO Inc.
  • Sangamo Therapeutics
  • Shire (Takeda Pharmaceutical Company Limited)
  • Ultragenyx Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Intravenous
  5. 1.2.3 Intracerebroventricular (ICV)
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Mucopolysaccharidosis Treatment Growth Trends by Region
  13. 1.5.1 Global Mucopolysaccharidosis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Mucopolysaccharidosis Treatment Market Size by Region (2021-2026)
  15. 1.5.3 Mucopolysaccharidosis Treatment Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Mucopolysaccharidosis Treatment Market Dynamics
  1. 2.1 Mucopolysaccharidosis Treatment Industry Trends
  2. 2.2 Mucopolysaccharidosis Treatment Industry Drivers
  3. 2.3 Mucopolysaccharidosis Treatment Industry Opportunities and Challenges
  4. 2.4 Mucopolysaccharidosis Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Mucopolysaccharidosis Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Mucopolysaccharidosis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Mucopolysaccharidosis Treatment Key Company Head office and Area Served
  4. 3.4 Global Mucopolysaccharidosis Treatment Company, Product Type & Application
  5. 3.5 Global Mucopolysaccharidosis Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Mucopolysaccharidosis Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Mucopolysaccharidosis Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Mucopolysaccharidosis Treatment Tier 1, Tier 2, and Tier 3
4 Mucopolysaccharidosis Treatment Market by Type
  1. 4.1 Global Mucopolysaccharidosis Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Mucopolysaccharidosis Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Mucopolysaccharidosis Treatment Market Size Share by Type (2021-2032)
5 Mucopolysaccharidosis Treatment Market by Application
  1. 5.1 Global Mucopolysaccharidosis Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Mucopolysaccharidosis Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Mucopolysaccharidosis Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abeona Therapeutics Inc.
  2. 6.1.1 Abeona Therapeutics Inc. Company Information
  3. 6.1.2 Abeona Therapeutics Inc. Business Overview
  4. 6.1.3 Abeona Therapeutics Inc. Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abeona Therapeutics Inc. Mucopolysaccharidosis Treatment Product Portfolio
  6. 6.1.5 Abeona Therapeutics Inc. Recent Developments
  7. 6.2 ArmaGen
  8. 6.2.1 ArmaGen Company Information
  9. 6.2.2 ArmaGen Business Overview
  10. 6.2.3 ArmaGen Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 ArmaGen Mucopolysaccharidosis Treatment Product Portfolio
  12. 6.2.5 ArmaGen Recent Developments
  13. 6.3 BioMarin
  14. 6.3.1 BioMarin Company Information
  15. 6.3.2 BioMarin Business Overview
  16. 6.3.3 BioMarin Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 BioMarin Mucopolysaccharidosis Treatment Product Portfolio
  18. 6.3.5 BioMarin Recent Developments
  19. 6.4 Denali Therapeutics
  20. 6.4.1 Denali Therapeutics Company Information
  21. 6.4.2 Denali Therapeutics Business Overview
  22. 6.4.3 Denali Therapeutics Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Denali Therapeutics Mucopolysaccharidosis Treatment Product Portfolio
  24. 6.4.5 Denali Therapeutics Recent Developments
  25. 6.5 Genzyme Corporation
  26. 6.5.1 Genzyme Corporation Company Information
  27. 6.5.2 Genzyme Corporation Business Overview
  28. 6.5.3 Genzyme Corporation Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Genzyme Corporation Mucopolysaccharidosis Treatment Product Portfolio
  30. 6.5.5 Genzyme Corporation Recent Developments
  31. 6.6 Lysogene
  32. 6.6.1 Lysogene Company Information
  33. 6.6.2 Lysogene Business Overview
  34. 6.6.3 Lysogene Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lysogene Mucopolysaccharidosis Treatment Product Portfolio
  36. 6.6.5 Lysogene Recent Developments
  37. 6.7 REGENXBIO Inc.
  38. 6.7.1 REGENXBIO Inc. Company Information
  39. 6.7.2 REGENXBIO Inc. Business Overview
  40. 6.7.3 REGENXBIO Inc. Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 REGENXBIO Inc. Mucopolysaccharidosis Treatment Product Portfolio
  42. 6.7.5 REGENXBIO Inc. Recent Developments
  43. 6.8 Sangamo Therapeutics
  44. 6.8.1 Sangamo Therapeutics Company Information
  45. 6.8.2 Sangamo Therapeutics Business Overview
  46. 6.8.3 Sangamo Therapeutics Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Sangamo Therapeutics Mucopolysaccharidosis Treatment Product Portfolio
  48. 6.8.5 Sangamo Therapeutics Recent Developments
  49. 6.9 Shire (Takeda Pharmaceutical Company Limited)
  50. 6.9.1 Shire (Takeda Pharmaceutical Company Limited) Company Information
  51. 6.9.2 Shire (Takeda Pharmaceutical Company Limited) Business Overview
  52. 6.9.3 Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Treatment Product Portfolio
  54. 6.9.5 Shire (Takeda Pharmaceutical Company Limited) Recent Developments
  55. 6.10 Ultragenyx Pharmaceutical
  56. 6.10.1 Ultragenyx Pharmaceutical Company Information
  57. 6.10.2 Ultragenyx Pharmaceutical Business Overview
  58. 6.10.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Ultragenyx Pharmaceutical Mucopolysaccharidosis Treatment Product Portfolio
  60. 6.10.5 Ultragenyx Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Mucopolysaccharidosis Treatment Market Size (2021-2032)
  2. 7.2 North America Mucopolysaccharidosis Treatment Market Size by Type
  3. 7.2.1 North America Mucopolysaccharidosis Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Mucopolysaccharidosis Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Mucopolysaccharidosis Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Mucopolysaccharidosis Treatment Market Size by Application
  7. 7.3.1 North America Mucopolysaccharidosis Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Mucopolysaccharidosis Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Mucopolysaccharidosis Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Mucopolysaccharidosis Treatment Market Size by Country
  11. 7.4.1 North America Mucopolysaccharidosis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Mucopolysaccharidosis Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Mucopolysaccharidosis Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Mucopolysaccharidosis Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Mucopolysaccharidosis Treatment Market Size (2021-2032)
  2. 8.2 Europe Mucopolysaccharidosis Treatment Market Size by Type
  3. 8.2.1 Europe Mucopolysaccharidosis Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Mucopolysaccharidosis Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Mucopolysaccharidosis Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Mucopolysaccharidosis Treatment Market Size by Application
  7. 8.3.1 Europe Mucopolysaccharidosis Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Mucopolysaccharidosis Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Mucopolysaccharidosis Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Mucopolysaccharidosis Treatment Market Size by Country
  11. 8.4.1 Europe Mucopolysaccharidosis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Mucopolysaccharidosis Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Mucopolysaccharidosis Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Mucopolysaccharidosis Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Mucopolysaccharidosis Treatment Market Size (2021-2032)
  2. 9.2 China Mucopolysaccharidosis Treatment Market Size by Type
  3. 9.2.1 China Mucopolysaccharidosis Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Mucopolysaccharidosis Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Mucopolysaccharidosis Treatment Market Share by Type (2021-2032)
  6. 9.3 China Mucopolysaccharidosis Treatment Market Size by Application
  7. 9.3.1 China Mucopolysaccharidosis Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Mucopolysaccharidosis Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Mucopolysaccharidosis Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Mucopolysaccharidosis Treatment Market Size (2021-2032)
  2. 10.2 Asia Mucopolysaccharidosis Treatment Market Size by Type
  3. 10.2.1 Asia Mucopolysaccharidosis Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Mucopolysaccharidosis Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Mucopolysaccharidosis Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Mucopolysaccharidosis Treatment Market Size by Application
  7. 10.3.1 Asia Mucopolysaccharidosis Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Mucopolysaccharidosis Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Mucopolysaccharidosis Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Mucopolysaccharidosis Treatment Market Size by Country
  11. 10.4.1 Asia Mucopolysaccharidosis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Mucopolysaccharidosis Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Mucopolysaccharidosis Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Mucopolysaccharidosis Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Mucopolysaccharidosis Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst